Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-207769
Filing Date
2024-08-27
Accepted
2024-08-27 16:08:55
Documents
1
Effectiveness Date
2024-08-27

Document Format Files

Seq Description Document Type Size
1 S-8 POS d843220ds8pos.htm S-8 POS 21962
  Complete submission text file 0001193125-24-207769.txt   22980
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-263400 | Film No.: 241249067
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)